Dulla, Baby Boy N.

HRN: 21-57-12  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2022
AMPICILLIN 250MG (VIAL)
07/08/2022
07/14/2022
IVT
140 Mg
Q12
Neonatal Asphyxia
Waiting Final Action 
07/08/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/08/2022
07/14/2022
IVT
14 Mg
Q24
Neonatal Asphyxia
Waiting Final Action 
07/08/2022
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
07/08/2022
07/14/2022
TOPICAL
Apply Thinly
Single Dose
Credes Prophylaxis
Waiting Final Action 
07/12/2022
CEFOTAXIME 500MG (VIAL)
07/12/2022
07/18/2022
IV
140mg
Q12
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: